ADIPOR1 and diabetes mellitus: These findings help explain the general phenomenon of the accelerated development of diabetes in smokers, and may also help us understand that inhibiting AdipoR1 ubiquitination as a novel therapeutic target holds promise to prevent nicotine-induced diabetic endothelial dysfunction.